Zucker School of Medicine at Hofstra/Northwell (North Shore University Hospital/LIJ)
Radiation Oncology residency · Manhasset, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Donald & Barbara Zucker School of Medicine at Hofstra/Northwell's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Donald & Barbara Zucker School of Medicine at Hofstra/Northwellinstitution-wide radiation oncology research
Radiation Oncology publications from Donald & Barbara Zucker School of Medicine at Hofstra/Northwell + Northwell Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
180
works per year
28th of 47 radiation oncology residency programs
+22.2%
2-year growth
11th of 47 radiation oncology residency programs
12.7%
in top 10% of field (works before 2025)
44th of 47 radiation oncology residency programs
28.4%
cited above world average
45th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 697Radiology, Nuclear Medicine and Imaging · 226
Radiation Oncology research topics at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Papers in the window; each links to the list on OpenAlex.
- Pancreatic and Hepatic Oncology Research 171
- Cancer Immunotherapy and Biomarkers 95
- Cancer survivorship and care 49
- Cutaneous Melanoma Detection and Management 44
- Cardiac Imaging and Diagnostics 42
- Colorectal Cancer Surgical Treatments 39
- Colorectal Cancer Treatments and Studies 38
- COVID-19 and healthcare impacts 28
Most cited at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell since 2024
All radiation oncology papers there on OpenAlex
- Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Andreas Schett et al. · Nature Reviews Rheumatology · 2024 · PubMed · cited 274
- Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron James Scott et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 204
- CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis et al. · Nature · 2024 · PubMed · cited 201
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0Gad Abikhzer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · PubMed · cited 111
- Prospective deep learning–based quantitative assessment of coronary plaque by computed tomography angiography compared with intravascular ultrasound: the REVEALPLAQUE studyJagat Narula et al. · European Heart Journal - Cardiovascular Imaging · 2024 · PubMed · cited 95
- REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic CancerUgo Boggi et al. · Annals of Surgery · 2024 · PubMed · cited 75
- Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrologySandra M. Herrmann et al. · Kidney International · 2024 · PubMed · cited 70
- DAMPs and radiation injurySatoshi Yamaga et al. · Frontiers in Immunology · 2024 · PubMed · cited 67
- Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2025 · PubMed · cited 61